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ABSTRACT 
 
Introduction 
 
Little is known about the association between maternal HIV status and the 
development of necrotizing enterocolitis (NEC) in premature infants. The 
few studies that have been published give no clear picture. In the light of 
the high maternal HIV infection in South Africa, it is important to explore 
the association between maternal HIV infection and all aspects of the 
paediatric population. 
 
Objectives 
 
The primary objective of this study was to determine if maternal HIV 
positive status was associated with the development of NEC in preterm 
infants who were born in one of our academic hospitals.  
The second objective was to determine the severity, need for surgery and 
mortality of preterm infants with NEC according to maternal HIV status. 
Finally, the third objective was to determine risk factors associated with 
NEC. 
 
Method 
 
The study population included preterm newborns less than 1500 grams 
born at the CMJAH and admitted to the neonatal unit within 24 hours of 
birth. Data on maternal and infant characteristics were collected from the 
computerized neonatal database from January 2006 to December 2013.  
 
Results 
 
A total of 2355 infants <1500g constituted the study population.  Of these 
126 met the inclusion criteria for NEC and 2229 did not. Therefore, large 
proportions were not entered for a multivariate analysis. 
 
Univariate analysis did not demonstrate an association between maternal 
HIV positive status and NEC (OR: 1.3, 95% CI: 0.8-1.9, p= 0.2). Therefore 
it was not entered into the multivariate analysis. 
 
On multivariate analysis antenatal corticosteroids showed a protective 
association with NEC (OR: 0.2, 95% CI: 0.1-0.4, p< 0.05). Multiple 
pregnancy and the need for resuscitation at birth was associated with NEC 
(OR: 1.6, 95% CI: 1-2.5, p= 0.03), (OR: 8, 95% CI: 4.5-15, p< 0.05), 
respectively. 
 v 
 
The analysis also found that severity of NEC, the need for surgery and 
mortality among infants with NEC did not differ according to maternal 
HIV status (p= 0.9, p=0.7 and p= 0.4), respectively. 
 
 
 
Conclusions 
 
The analysis was not able to demonstrate an association between maternal 
HIV positivity and the risk of NEC. Risk factors for NEC that were 
identified were multiple pregnancies and the need for resuscitation at birth. 
Antenatal corticosteroids were found to have a protective association with 
NEC. 
Finally, severity, need for surgery and mortality did not also differ 
according to maternal HIV status among the NEC group. 
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1. Introduction 
 
Necrotizing enterocolitis (NEC) is a condition primarily seen in premature 
infants, where portions of the bowel undergo necrosis as a result of severe 
inflammation. Any part of the bowel may be involved, but typically the 
ileum and the proximal colon are affected.
1, 2 
 
 
From a neonatal and surgical perspective, it is reported as the most 
common acquired gastrointestinal disease and contributes to a significant 
extent to morbidity and mortality in very low birth weight infants (birth 
weight less than 1500 grams, VLBW infants). 
 
The historical background of the disease goes back to its initial description 
by Genersich in 1891.
3
 The disease occurred in a 45-hour-old premature 
infant who developed vomiting, cyanosis and abdominal distension. Death 
occurred rapidly, within 24 hours of being symptomatic. The post mortem 
examination revealed areas of inflammation and perforation of the ileum. 
Thereafter, several reports of unexplained perforation of the intestinal tract 
in the newborn emerged. 
 
Rossier, Sarrut and Delplanque, in 1959, reviewed 15 infants with 
“malignant enteritis”, as termed in 1944 by Willi. The review enabled them 
to give a thorough clinical and pathological description of the condition. 
Hence, they described it as ulcerative necrotic enterocolitis of the 
premature infant.
3
 In 1975 Santulli and colleagues described the condition 
in 64 premature infants. Three factors were reported to be important in the 
development of the disease: injury to the intestinal mucosa, feeding and 
bacteria.
4
 It was also noted that the disease carried a high morbidity and 
mortality.  
 
However, improved outcome occurred with the institution of early and 
aggressive treatment. Since then, numerous descriptions of NEC have 
provided a better understanding of the disease in terms of its risk factors, 
pathogenesis, manifestations and mortality. Studies have shown that the 
incidence of NEC shows a clear and inverse relationship with the birth 
weight and the gestation age.
1, 5 
The incidence and mortality of NEC varies 
from country to country and from one neonatal unit to the other.
 
 
South Africa has experienced a major epidemic with regards to Human 
Immunodeficiency Virus (HIV) infection since the 1990s. The national 
department of health in 2011 reported the antenatal HIV prevalence at 
29.5% (95% CI: 28.7-30.2).
6 
 2 
 
Recent data from UNICEF in 2014 reported that the estimated number of 
pregnant women living with HIV delivering in South Africa was 260 000.
7
 
Little is also known about the association between maternal exposure to 
HIV and NEC and there are only a few published studies on this in the 
literature, with conflicting results. 
 
The aim of this study was to test the hypothesis that premature infants born 
to HIV positive mothers are at greater risk for developing NEC than those 
unexposed. 
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2.0 LITERATURE REVIEW 
 
In high income countries such as the United States of America (USA) and 
Canada the incidence and mortality from NEC is either stable or decreasing 
as a result of early detection, sepsis management and availability of 
intensive care facilities.
8
 In Canada, population based or multi center 
epidemiological studies reported that NEC rates stabilized over recent 
decades for VLBW infants, ranging between 6% and 7%.
9,10,11
 In contrast 
to these findings, a study performed by the New South Wales and 
Australian Capital Territory Neonatal Intensive Care Unit Study group 
(NSW ACT NICU), reported a reduction in the incidence of NEC from 12 
% in 1986-1987 and 1992-1993 to 6% in 1998-1999 for all infants born at 
24 to 28 weeks’ gestation.9  In other developed countries, NEC has a similar 
incidence and the mortality rate ranges from 12 to 30%.
9,12
 The mortality 
rates are reported to be higher in infants requiring surgery than in those 
medically treated for NEC with case fatality rates for those requiring 
surgery as high as 50%.
9 
 
In South Africa, a recent study conducted at the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) neonatal unit reported an 
incidence of NEC of 5.6% for all VLBW infants admitted in 2006/2007 
and 7.3% in 2013.
8 
The overall mortality of cases of NEC at CMJAH is 
high at 43.9% as reported in the same study.
8  
Thus the incidence of NEC 
may be showing an increasing trend. However, it remains similar to the 
incidence in developed countries such as USA (6 to 7.1%) and Canada 
(6.6%). 
9,10, 11
. 
 
As stated previously there are few studies looking at the association of 
neonates born to HIV positive mothers and NEC. 
 
Desfrere et al, in a retrospective case control study questioned if being born 
to an HIV-positive mother increased the risk of NEC in premature 
infants.
13 
The study comprised 79 cases of NEC, which were compared 
with 158 controls. The results showed an increased frequency of HIV 
positive mothers in infants who subsequently developed NEC (OR, 6.63; 
95% CI, 1.26-34.8; p=0.025) suggesting that there is an association 
between HIV positive mothers and NEC developing in their infants if born 
prematurely.
13
 However, Angura and Velaphi, in a retrospective case 
control study at the Chris Hani Baragwanath Academic Hospital analyzed 
risk factors for necrotizing enterocolitis in an HIV- endemic region and 
found that maternal HIV status was not associated with the development of 
NEC (OR: 1.14, 95% CI: 0.71-1.82, p=0.58).
14 
 4 
 
Marion et al in a retrospective study found that HIV-exposed infants did 
not have more severe disease and adverse outcome (stage 3b) than 
unexposed infants. 
25
  
  
Karpelowsky et al assessed the impact of HIV exposure on survival and 
extent of disease in NEC. They found that neonates with NEC born to HIV 
positive mothers had a higher mortality compared to those born to HIV 
negative mothers. However, the study also found that there was no 
difference in the extent of the disease between the two groups.
15
  
 
 
2.1 Pathology and Pathophysiology 
 
NEC initially involves the gastrointestinal system, and may then be 
followed by profound systemic effects. Pathological findings vary and 
depend on the progression of the disease as well as the presence of 
underlying factors
16
. Gross examination in most cases reveals distended, 
hemorrhagic loops of bowel, sub-serosal collections of gas, intra-
abdominal fluid collection and intestinal perforation in severe cases. With 
healing, thickening of the bowel wall, fibrous adhesions and areas of 
stenosis may develop
16
. Major histological findings in NEC include 
mucosal edema, hemorrhage, transmural necrosis and acute inflammation 
secondary to bacterial infiltration
16
. 
 
Its pathophysiology is poorly understood. However, immaturity of key 
functions due to prematurity such as loss of gastrointestinal motility, 
digestive ability, circulatory regulation, intestinal barrier function and 
immune defenses are all thought to play a role in its development
17
.  
Other contributing factors include feeding with formula and colonization 
by pathological bacteria
17
. 
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2. 2 Prematurity 
 
Prematurity remains the most important and consistent risk factor for NEC. 
About 90% percent of cases occur in premature infants who have been fed 
enterally
16
. The majority of patients affected by NEC are VLBW (birth 
weight less than 1500 grams) infants. The increased susceptibility to the 
disease is attributed to an immature mucosal barrier response, bowel 
motility and function, changes in intestinal micro flora, host defense 
mechanisms and increasing enteral volume. 
 
Full term infants who develop NEC typically have specific risk factors 
such as congenital heart diseases, sepsis, perinatal asphyxia, polycythemia, 
and respiratory disease
16
. In fact, any condition that causes reduction in the 
mesenteric perfusion may allow NEC to develop. 
 
 
2. 3 Immature intestinal motility, digestion and function 
Intestinal motility is an important factor in removing antigens presented to 
the intestinal mucosal barrier from the gut lumen
5
. Fetal studies in both 
humans and animals proposed that development of gastrointestinal motility 
begins in the second trimester, but this matures in the third trimester.
14, 15
 
Study of intestinal motility shows that premature infants have immature 
motility patterns when compared to full -term infants
5
.  
Maternal hypertension and fetal disease such as intrauterine growth 
restriction might induce fetal hypoxia. These can reduce postnatal intestinal 
motility because of an alteration in the peristaltic mechanism and a poor 
digestive and absorptive ability.
12
 The intrinsic enteric nervous system is 
affected and predisposes the infants to poor clearance of bacteria, entry of 
pathogens from the environment, exponential growth of anaerobic bacteria 
in the small intestine with malabsorption of nutrients.
9
 In addition, 
premature infants do not have the complete ability to fully digest   
nutrients.
12
 Therefore, incompletely digested molecules contribute to 
intestinal injury and development of NEC. 
 
 
2.4 Immature intestinal immunity 
It is well known that the fetus lacks a functional immune system and has a 
sterile gastrointestinal tract initially. However, exposure of the newborn 
infant to bacteria colonized in the mother vaginal canal and the skin as well 
 6 
as immunological factors in the breast milk result in the gut becoming 
colonized with bacteria
2
. 
Immunity of the newborn gut is provided through several mechanisms: 
enhancement of intestinal salt secretion, water absorption, secretion of IgA, 
expression of antimicrobial proteins and production of intestinal mucus. 
However, in the preterm infant, immaturity of those mechanisms results in 
selective movement of small ions across the intestinal monolayer, inability 
of secretory IgA to bind to bacteria and to remove harmful pathogens or 
toxins.
9 
 
2.5 Abnormal bacterial colonization  
 Bacteria and viruses have been linked to outbreaks of NEC. Examples of 
bacteria include: Clostridium species, Klebsiella species and 
Staphylococcus epidermis.
2
 Unfortunately, no single pathogen has been 
identified as a causative agent. It is important to highlight the ability of the 
microflora to colonize the epithelium and to ferment unabsorbed nutrients.
2 
Colonization of the gastrointestinal tract in the premature infant is different  
from the healthy term infant.
11
 Premature infants have less species diversity 
and fewer anaerobic species of Lactobacillus and Bifidobacterium than 
term infants.
11
 They are also more likely to be populated by pathogenic 
bacteria, such as Klebsiella, Enterobacter and Clostridium organisms. This 
imbalance represents a fertile environment for pathological overgrowth of 
bacteria, which in turn is capable of triggering an inflammatory response.
11 
 
A case-control study by De la Cochetiere and colleagues analyzing the 
relationship between the gut colonization and NEC showed evidence of a 
temporal relationship between abnormal bacterial colonization and the later 
development of NEC.
18 
 
2.6 Genetic susceptibility 
Although current technology allows for the detection and evaluation of 
genetic polymorphisms and their influence on disease development, no 
studies have shown a genetic or familial link with the development of 
NEC
17
. 
With regard to the hypothesis of this study, it would be expected that both 
intestinal immunity and abnormal bacterial colonization in HIV exposed 
infants may be affected and predispose these infants to NE 
 7 
 
2.7  Clinical risk factors 
A review article by Bhoomika and Shah summarized the clinical risk 
factors for NEC.
17 
These included: 
 Prematurity (< 28 weeks) 
 Enteral feeding (90 % were fed by enteral route) 
 Presence of certain bacteria within the gut lumen 
 Hypoxic insult 
 Intrauterine growth restriction  
 Pregnancy induced hypertension 
 Placental abruption 
 Absent or reversed end diastolic flow velocity 
 Umbilical catheterization 
 Low Apgar scores 
 Blood transfusions 
 
2.8 Protective factors 
Several factors have been shown to be associated with a decreased risk of 
NEC through various mechanisms. 
- Human breast milk protects against NEC by inhibiting gut colonization 
by pathogenic flora, enhancing maturation of the intestinal barrier and 
controlling the pro-inflammatory response.
19
 A study by the National 
Institute of Child Health and Human Development Neonatal Network has 
showed that breast milk feeding is associated with a reduced risk of NEC 
or death after the first two weeks of life among extremely low birth weight 
infants.
20 
 8 
- Probiotics: these are live microorganisms that colonize the 
gastrointestinal tract. They provide health benefit on the host when 
administered in adequate amount. The most frequently used probiotics are 
Lactobacillus and Bifidobacterium. They provide protection against the 
development of NEC by preventing bacterial migration across the intestinal 
mucosa.
19
 In a 2014 Cochrane review twenty four randomized clinical trials 
and more than 5000 preterm infants were included. The evidence showed 
that probiotics reduces the risk of severe NEC and all cause mortality in 
preterm infants.
21 
- Prebiotics are indigestible substances that selectively promote growth and 
colonization of the probiotic lactobacilli or Bifidobacterium. They have 
also shown to decrease the incidence of NEC.
17, 19
 
Additional protective factors include provision of antenatal corticosteroids, 
fluid restriction, immunonutrition (Glutamine and Arginine) and 
polyunsaturated fatty acid supplements (Phospholipids), enteral antibiotics, 
feeding strategies (Trophic feeding and Standardized Feeding Regimens), 
Synbiotics, Lactoferrin supplement, acidification of Gastric contents and 
Epidermal growth factor (EGF). 
17
 
 
2.9 Clinical presentation 
The onset of the disease can occur suddenly within a few hours or may be 
preceded by days of feeding intolerance. Initial symptoms may be subtle 
and include feeding intolerance, abdominal distension, temperature 
instability, lethargy, decreased peripheral perfusion, apnea and bloody 
stools. 
Kiegman et al
 
modified the Bell staging criteria for neonatal NEC.
22
 It 
provided a classification according to signs, symptoms, degree of systemic 
involvement and radiological signs (appendix A). 
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3.0 METHODOLOGY 
 
3.1 Research question 
 
Does maternal HIV positivity increase the risk of NEC in premature 
infants? 
 
3.2 Objectives 
 
  3.2.1 Primary objective 
To determine if maternal HIV positive status is associated with the 
development of NEC in preterm infants who were born at CMJAH or 
admitted within 24 hours of birth. 
3.2.2 Secondary objective 
 To compare the severity, need for surgery and mortality of preterm 
infants with NEC according to maternal HIV status. 
 
 To determine risk factors for the development of NEC according to 
maternal and infant characteristics. 
3.3 Study design  
This was a retrospective descriptive and comparative study 
3.4 Source of Data 
Data was obtained from the computerized neonatal database between 
March 2006 and December 2013. 
Infants weighing less than 1500g at birth were selected on the basis that 
most infants with NEC would be found in this group. 
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3.5 Study Population 
A total of 10802 infants were admitted over this period. 
 8447 patients were excluded for the following reasons: 
 Birth weight above 1500 grams 
 Infants referred after 24 hours of life to CMJAH. 
 Major congenital abnormalities such as gastroschisis, duodenal atresia 
and others. 
Cases were defined as VLBW infants who were diagnosed with NEC stage 
2 or 3 based on the Modified Bell’s classification (appendix A).  Infants 
with stage 1 NEC were not included as these are regarded only as 
suspected NEC according to this classification. 
Of the 2355 infants who met the inclusion criteria, 126 infants met the 
inclusion criteria for cases (stage 2 or 3 NEC). The remaining infants 2229 
were either not affected by NEC or were suspected cases of NEC, (stage 1) 
as defined by the Modified Bell’s classification and formed the comparison 
group. 
 
 
3.6 Sample size 
 
The number of NEC cases meeting the criteria for enrollment 
predetermined the sample size. 
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3.7 Characteristics to be analyzed as risk factors 
 
3.7.1 Maternal characteristics 
a) Maternal HIV status 
b) Multiple pregnancies 
c) Maternal steroids 
 
3.7.2 Infant Characteristics 
a) Gestational age 
b) Birth weight 
c) Gender 
d) Need for resuscitation 
The need for ventilation and the type of feeding were planned to be 
analyzed as risk factors.  However, the database did not differentiate 
between those ventilated in the early neonatal period and those ventilated 
as a result of NEC so this could not be analyzed as a risk factor. The data 
on feeding in the database only specified the type of feeding on discharge 
and not in the period prior to the development of NEC and this variable 
also could thus not be analyzed as a risk factor. 
 
3.7.3 Outcome 
a) Stage of NEC (severity) 
b) Need for surgery 
c) Mortality 
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3. 8 Data processing and analysis 
The neonatal data was provided in a Microsoft spreadsheet Excel program. 
After identification of cases and non-cases of NEC, the selected data were 
entered in STATA 12.0 statistical program for analysis. 
Summary statistics was used to describe maternal and infant characteristics. 
Two sample t-tests with equal variance were used to determine the mean 
for birth weight and gestational age between the two groups (NEC and non-
NEC cases). 
Univariate and Multivariate logistic regression analysis were used to 
determine maternal and infant risk factors associated with NEC.  
Odds ratios were reported using a 95% confidence interval and a 
significant association was reported using a p-value of less than 0.05 for 
both univariate and multivariate analysis. 
Finally, the chi square test was used to compare severity, mortality and the 
need for surgery in the NEC group as well as determine a probable 
association among variables according to maternal HIV status. 
 
3. 9 Ethics and Authorization 
 
The Protocol Review Committee and the Human Research Ethics 
Committee of the University of the Witwatersrand approved the study. 
(Refer to appendix B). 
Permission to use the neonatal database was obtained from the Chef 
Executive Officer of CMJAH (Refer to appendix C). 
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4.0 RESULTS 
 
4.1 Statistical description of data 
 
Maternal characteristics regarding HIV status, administration of antenatal 
steroids and multiple pregnancies for infants with and without NEC can be 
seen in Table 1. The total number of mothers with a positive HIV status in 
both groups (NEC and non NEC) was 569 (25.5%) and 51 (40.5%), 
respectively as seen in Table 1. The statistical description also showed that 
many of the mothers had unknown HIV status and the recording of 
antenatal steroids in the database was also poor.  
 
Table 1: Statistical description of maternal characteristics 
 
Variables  
NEC (n=126) 
(%) 
 
No NEC 
(n=2229) (%) 
Maternal HIV status 
Negative 
Positive 
Unknown 
 
57 (45.2) 
51(40.5) 
18 (14.3) 
 
840 (37.7) 
569 (25.5) 
820 (36.8) 
Maternal steroids 
Yes 
No  
Unknown 
 
38 (30.4) 
40 (32.0) 
48 (37.6) 
 
767 (34.4) 
275 (12.3) 
1187 (53.3) 
Multiple pregnancy 
Yes 
No 
Unknown 
 
28 (22.2) 
92 (73.0) 
6 (4.8) 
 
373 (16.7) 
1737 (78.0) 
119 (5.3) 
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Neonate’s characteristics are seen in Table 2. 
The mean birth weight and gestational age for both groups were similar. 
Others variables such as gender and the need for resuscitation are also seen 
in Table 2. 
 
Table 2: Statistical description of neonates with NEC as compared to 
those without NEC  
 
* Standard deviation (SD) 
 
 
Variables 
 
NEC (n=126)   
(±SD) or (%)  
 
No NEC (n=2229) 
(±SD) or (%) 
 
p- value 
Mean birth 
weight (grams) 
 
1138 (±185)
* 
 
 
1150 (±236)
* 
 
0.5 
Mean gestational 
age (weeks) 
 
29 (±2.5)
* 
 
 
28 (±6.3)
* 
 
0.1 
Gender 
Female 
 
Male 
 
Unknown 
 
59 (46.8) 
67 (53.2) 
 
0 
 
1182 (53.0) 
1034 (46.4) 
 
13(0.6) 
 
0.2 
Need for 
resuscitation 
Yes 
 
NO 
 
Unknown 
 
 
92 (73.0) 
20 (15.9) 
14 (11.1) 
 
 
688 (30.9) 
1541 (69.1) 
 
0 
 
 
<0.05 
 15 
 
 
 
 
Statistical description of outcomes can be seen in Table 3.  
The majority of babies with NEC had stage 3 (60%) and 28.9% required 
surgery. Overall survival of those with NEC was significantly lower than 
the group without NEC.  
 
 
Table 3: Outcomes of neonates with NEC as compared to those 
without NEC  
 
Outcomes NEC n=126 
(%) 
No NEC 
n=2229 (%) 
p- value 
Stage of NEC 
Stage 2 
Stage 3 
Unknown 
 
 
20 (15.9) 
76 (60.3) 
30 (23.8) 
 
 
N/A 
 
 
- 
 
Surgery 
Yes 
No 
Unknown 
 
 
36 (28.6) 
49(38.9) 
41(32.5) 
 
 
N/A 
 
 
- 
Mortality 
Yes      
No 
Unknown 
 
 
 
61(48.4) 
65 (51.6) 
0 
 
 
479 (21.7) 
1731(78.3) 
19 (0.9) 
 
 
<0.05 
 
 
 
 
 
 
 16 
4.2 Risk factors associated with NEC 
 
It is important to highlight that all variables had missing data. In tables 1, 2 
and 3, the missing data in all of the variables used can be seen. However, in 
order to obtain accurate statistical results unknown data were excluded. 
In instances where a high number of missing data was noted, the variable 
had to be excluded from the statistical analysis. 
Statistical description of maternal characteristics, neonates with NEC and 
those without NEC as well as their outcome, provided an overview of all 
data available before the analysis.  
 
Table 4 shows the univariate and multivariate analysis on risk factors 
associated with NEC. 
 
The univariate analysis showed that there was no significant association 
between maternal HIV and the development of NEC (OR: 1.3, 95% CI: 
0.8-1.9 and p = 0.2) and it was therefore not entered into the multivariate 
analysis.  
 
Provision of maternal steroids showed a protective association with NEC 
on both the univariate and multivariate analysis. Multiple pregnancy and 
the need for resuscitation at birth also showed an association with NEC as 
noted in Table 4. 
  
Other variables such as mean birth weight, mean gestational age and 
gender did not show any association with NEC. Multivariate analysis was 
not done for those variables.   
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Table 4: Risk factors associated with NEC on univariate and 
multivariate analysis. 
 
 
 
 
 
 
 
 
 
Characteristics 
Univariate analysis Multivariate analysis 
 
Odds 
ratio 
95% 
Confidence 
interval 
p-value Odds 
ratio 
95% 
Confidence 
interval 
p-value 
Maternal HIV 
status 
 
1.3 
 
0.8-1.9 
 
0.2 
 
- 
 
- 
 
- 
Maternal antenatal 
steroids 
 
0.2 
 
0.1-0.4 
 
<0.05 
 
0.2 
 
0.1-0.4 
 
<0.05 
Multiple 
pregnancy 
 
1.6 
 
1-2.5 
 
0.03 
 
1.8 
 
1-3.3 
 
0.04 
Mean birth weight 
 
0.9 
 
0.9-1 
 
0.4 
 
- 
 
- 
 
- 
Mean gestational 
age 
 
1 
 
0.8-1 
 
0.5 
 
- 
 
- 
 
 
- 
 
Gender 
 
0.8 
 
0.5-1.3 
 
0.5 
 
- 
 
- 
 
- 
Need for 
Resuscitation at 
birth 
 
8 
 
4.5-15 
 
<0.05 
 
9 
 
5-16 
 
<0.05 
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4. 3 Severity and Outcome of infant with NEC according to maternal 
HIV status  
 
The analysis did not demonstrate any difference in severity, need for 
surgery or mortality among infants with NEC according to maternal HIV 
status, as can be seen in Tables 5, 6 and 7. 
 
Table 5: Severity of NEC according to maternal HIV status 
 
 Maternal HIV status 
Stage of 
NEC 
(severity) 
Positive Negative Total 
Stage 2 
20 22 
 
42 
Stage 3 
31 35 66 
Total 
51 57 108 
Pearson chi2 (1): 0.004, p-value: 0.9 
 
Table 6: Need for surgery for NEC according to maternal HIV status 
 
 Maternal HIV Status 
Surgery Positive Negative 
Total 
No 20 24 
44 
Yes 11 16 
27 
Total 31 40 
71 
Pearson chi 2 (1): 0.1, p value: 0.7 
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Table 7: Mortality of NEC infants according to maternal HIV status 
  
 Maternal HIV status 
Mortality 
Positive Negative Total 
Death 
27 26 53 
Survival 
24 31 55 
Total 
51 57 108 
Pearson chi2 (1):0, 57   p value: 0.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
5.0 DISCUSSION 
 
As previously stated, data published from this database showed an NEC 
incidence of 5.6% for VLBW infants at CMJAH in 2006 and an incidence 
of 7.3% per VLBW in 2013.
8 
In the current study, 126 NEC cases meeting 
the inclusion criteria were found, providing an incidence of 5.6%. Thus, it 
would seem that most cases of NEC were captured in the routine collection 
of data for this database when compared with the more detailed data 
collection that was required for the above studies. 
 
There was a trend towards more mothers in the NEC group testing positive 
for HIV (40.5%) compared with the control group (25.5%). However, the 
study was not able to show a significant association between maternal HIV 
positivity and NEC since this did not reach statistical significance. This 
finding is consistent with a retrospective case control study by Angura and 
Velaphi at Chris Hani Baragwanath Academic Hospital.
14
  
 
 
Administration of antenatal steroids has been shown to improve digestive 
functions. They also provide an anti-inflammatory effect on the gut. A 
study by Crowley on the effects of antenatal corticosteroids showed that 
this drug was associated with a reduction in the incidence of RDS, IVH and 
NEC.
4 
In this analysis, both univariate and multivariate logistic regression 
showed that the provision of antenatal corticosteroids was a protective 
factor for NEC. For many infants in the database there was no indication as 
to whether the mother had received antenatal steroids, but it seemed that a 
large number of VLBW infants did not have the benefit of this intervention 
mainly due to late maternal presentation and limited opportunities for the 
obstetrician to provide antenatal steroids. 
 
Most newborns in both groups (NEC and non NEC) were from singleton 
pregnancies: 73% and 78%, respectively. Zampieri et al reported that there 
was an increased incidence of NEC in multiple pregnancies only if the 
gestational age was less than 28 weeks.
 23
 Our population was confined to 
VLBW with a mean gestation age of 29 weeks. Despite a high number of 
singleton pregnancies compare to multiple pregnancies, the results from the 
univariate and multivariate analysis in this study revealed that multiple 
pregnancy was associated with NEC. Therefore, these findings are almost 
in keeping with the Zampieri study.  
 
Although, most studies have demonstrated that the incidence of NEC 
shows a clear and inverse relationship with the birth weight and gestational 
age
1, 5
 univariate analysis in this study did not show such an association. 
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Therefore these were not entered into the multivariate analysis. However, 
survival of infants with birth weight <1000 grams was low and most died 
in the early neonatal period. 
8
 A recent study done by Ballot et al showed a 
marked improvement in the neonatal survival of neonates weighing 
between 750 and 900 grams at birth due to provision of surfactant and 
nCPAP.
8
 As the survival of ELBW infants improves future studies in this 
unit may show the inverse relationship between NEC and birth weight that 
has been seen in other studies. 
 
 Neonatal risk factors for NEC in our population were the need for 
resuscitation at birth and multiple pregnancy. This was consistent with a 
Cochrane review by Singh et al on the neonatal outcome of extensive 
cardiopulmonary resuscitation in the delivery room for infants born at less 
than 33 weeks gestational age.
24
 Since many VLBW infants in our 
institution have inadequate antenatal and intrapartum care due to poor 
attendance at antenatal clinic and arrival in the hospital in advanced labour, 
improvement in these aspects of care may lead to a reduction in the 
incidence of NEC. 
 
Descriptive analysis of outcomes related to NEC showed that most infants 
had a severe form of NEC, stage 3 in 60% of participants. However, the 
degree of severity of the disease among those infants did not differ 
according to maternal HIV status. These results were consistent with 
Marion et al who found that HIV exposed newborns with NEC did not 
have a more severe disease than unexposed newborns.
25
  
 
Mortality among NEC infants with a positive maternal HIV status was not 
significantly higher compared to HIV negative mothers as seen in table 7. 
However, Karpelowsky et al found that infants with NEC born to HIV 
infected mothers had a higher mortality compared to those born to HIV 
negative mothers possibly explained by confounders such as, sepsis and co 
morbidity
.15
 However, our results did not show a significant increased risk 
to NEC mortality with regards to maternal HIV status. This was probably 
because of paucity of data. Therefore, we could not further analyze 
mortality among stages of NEC. Similarly, a study by Marion et al found 
that HIV does not worsen outcome in stage 3b NEC and that mortality 
from NEC did not differ between HIV exposed and non- HIV exposed 
neonates.
25
 Further study is needed to resolve this issue. 
 
 
 
The high mortality of NEC cases in this study is similar to that of previous 
studies in this unit.
8
 This may be due to the high incidence of stage 3 NEC.   
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This in turn may indicate that the early signs of NEC are being missed by 
the attending staff and should be an area to focus on in the future. 
 
5. 1 Limitations of the study 
The retrospective design of the study resulted in many missing data.  This 
study showed no difference in the incidence of NEC on the basis of 
maternal HIV status.  Most of the missing data for this variable occurred in 
the group who did not develop NEC.  There is no reason to believe that, 
had these data been more complete, the results would have changed, but 
there is no way to be sure of this.  Important variables such as the type of 
milk feeds provided and ventilation in the early neonatal period could not 
be analyzed due to inadequate data. However, improvements in data 
collection in this unit will improve the quality of data for future studies.  
 
6. CONCLUSION  
This study did not show an association between maternal HIV positivity 
and the development of NEC at the CMJAH. Severity, need for surgery and 
mortality due to NEC also did not differ according to maternal HIV status.  
Multiple pregnancy and the need for resuscitation at birth were identified 
as risk factors for NEC whereas antenatal steroids were associated with a 
reduction in NEC.  Improvements in the uptake of antenatal steroids and a 
reduction in the need for resuscitation at birth may reduce the incidence of 
NEC at CMJAH, while earlier diagnosis of NEC may improve the survival 
of those that do develop NEC. 
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APPENDIX A: Modified Bell classification 
 
 
 
 
 
 
 
 
 
 
Table 1. Modified Bell Staging Criteria for NEC  
Stage Classification Systemic sign Intestinal sign Radiological sign 
IA Suspected 
NEC 
Temperature instability, 
apnea, bradicardia, 
lethargy 
Increased pregavage 
residuals, mild abdominal 
distension, emesis, 
guaiac-positive stool 
Normal or intestinal 
dilatation, mild ileus 
IB Suspected 
NEC 
Same as above Bright red blood from 
rectun 
 Same as above 
IIA Proven NEC- 
mildly ill 
Same as above Same as above, plus 
absent bowel sounds, with 
or without abdominal 
tenderness 
Intestinal dilatation, 
ileus, pneumatosis 
intestinalis 
IIB Proven NEC- 
moderately ill 
Same as above, pus 
mild metabolic 
acidosis, mild 
thrombocytopenia 
Same as above, plus 
absent bowel sounds, 
definite abdominal 
tenderness, with or without 
abdominal cellulitis or right 
lower quadrant mass 
Same than IIA, plus 
portal venous gas, 
with or without 
ascites 
IIIA Advance NEC 
severely ill, 
bowel intact 
Same as IIB, plus 
hypotension, 
bradycardia, severe 
apnea, combined 
respiratory and 
metabolic acidosis, 
disseminated 
intravascular 
coagulation and 
neutropena 
Same as above, plus sign 
of generalozed 
peritonitis,marked 
tenderness and distension 
of abdomen 
Same as IIB, plus 
definite ascites 
IIIB Advance NEC 
severely ill, 
bowel 
perforated 
Same as IIIA Same as IIIA Same as IIB, plus 
pneumoperitoneum 
Adapted from Lee & Polin, 2003. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol. 2003;8:449–
459. 
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APPENDIX D: Data collection sheet for NEC study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code No (NEC)  
Maternal HIV 
status  
Positive/negative/unknown 
Multiple 
pregnancy 
Yes/No/unknown 
Maternal 
steroids 
Yes/No/unknown 
Gestational age  
Birth weight  
Gender  
Need for 
resuscitation at 
birth 
Yes/No/unknown 
Need for 
ventilation 
Yes/No/unknown 
Stage of NEC 
(Severity) 
 
Feeding Breast/Formula/Mixed/unknown 
Surgery Yes/No/unknown 
Mortality Yes/No/unknown 
